Table 1.
HC (n = 41) | PD (n = 41) | ||
---|---|---|---|
mean ± se | mean ± se | P value | |
Age (years) | 23.09 ± 0.44 | 24.02 ± 0.51 | >0.05 |
Education (years) | 18.01 ± 0.1 | 18.02 ± 0.13 | >0.05 |
Cycles (days) | 29.21 ± 0.17 | 29.44 ± 0.19 | >0.05 |
Age at menarche (years) | 12.21 ± 0.67 | 12.46 ± 0.84 | >0.05 |
History of menstrual pain (years) | — | 10.49 ± 1.1 | — |
Duration of menstrual pain (days) | — | 1.9 ± 0.38 | — |
Drug taken (%) | — | 21% | — |
Periovulatory phase | |||
PGF | 7.22 ± 0.7 | 10.58 ± 1.33 | >0.05 |
VAS | 0 | 0 | — |
SAS | 26.5 ± 1.0 | 28.24 ± 1.28 | >0.05 |
SDS | 27.1 ± 1.9 | 28.92 ± 1.16 | >0.05 |
Menstruation phase | |||
PGF | 6.96 ± 0.65 | 11.68 ± 1.16 | <0.00001 |
VAS | 0.34 ± 0.12 | 6.5 ± 0.23 | <0.00001 |
SAS | 27 ± 1.33 | 32.28 ± 1.8 | >0.05 |
SDS | 28.8 ± 1.58 | 34.36 ± 1.95 | >0.05 |
PD, primary dysmenorrhea; HC, healthy controls; PGF , prostaglandins F ; VAS, visual analogue scale; SAS, self‐rating anxiety scale; SDS, self‐rating distress scale; se, standard error.
The comparisons of subjects' basic information were performed between PDM and HC groups using two‐sample t test. P < 0.05 was considered significant. False discovery rate (FDR) was used to correct for multiple comparisons.